TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings.

Richard B Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.